HRA Latest, February 2022: Let's talk about ethics review; smoothing the way to confidentiality support and more...

Having trouble viewing this email? View it as a Web page.

NHS Health Research Authority

HRA Latest – 24 February 2022

Karen Williams, Deputy Chief Executive

Welcome to HRA Latest, with all the latest updates for those working or involved in health and social care research.

We’ve been finding out what you think is important in ethics review and who you trust to provide that review as part of our Think Ethics work. This month three members of our Public Involvement Network, Louise, Lynn and Della, have blogged about their experience as part of our workshops.

Making research approvals more simple is still one of our top priorities. Find out how we’re making applications more straightforward for studies that need both confidentiality and ethics review.

As always, for the latest news you can follow us on Twitter @HRA_Latest.

Karen Williams, Deputy Chief Executive

 

 


Think Ethics decorative image

Let's talk about ethics review 

We’ve been finding out what you think is important in ethics review and who you trust to provide that review. It’s part of our Think Ethics work, and this month three members of our Public Involvement Network, Louise, Lynn and Della, have blogged about their experience as part of our workshops.

 


Padlock

Smoothing the way to confidentiality support

As part of wider work to streamline our processes, we’re looking at how we can better align applications for studies that need both Confidentiality Advisory Group (CAG) advice and a Research Ethics Committee (REC) opinion.

A blog by Paul Mills, Confidentiality Advice Service Manager, explains the difference this could make.

 

Read the blog


Clinical trials

Now is your chance to improve public involvement in UK clinical trials 

We’re working with the Medicines and Healthcare products Regulatory Agency (MHRA) on proposals to improve and strengthen UK clinical trials legislation. Our Public Involvement Lead, Jim Elliott, blogs about how you can help inform change. 

 

Read the blog


Combined review no logos

 

 

Approval times for clinical trials halved with combined review

Combined review is now in place for all new clinical trials of medicines and combined medicine and device trials.

Timelines vary depending on the complexity of the application, but overall are twice as fast as they were in 2018.

Find out more


Hourglass

Reducing the time to set up commercial studies in the UK

We’re helping to reduce the time, cost and resources needed to set up health and social care research in the UK by launching new templates for studies that are sponsored by a commercial company.

More information